시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 오피오이드 시장 보고서(2025년)
Opioids Global Market Report 2025
상품코드 : 1694676
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,426,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,288,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,150,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

오피오이드 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보이며 2029년까지 연평균 3.3%의 성장률로 276억 2,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 성장은 비암성 통증 적응증, 규제 변화, 원격 의료 및 원격 처방, 만성 통증 관리에 기인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 오피오이드 보존 전략, 약수처리 지원(MAT), 위험 감소, 공중보건 노력 등이 있습니다.

외과 수술 증가는 당분간 오피오이드 시장 확대의 원동력이 될 것입니다. 수술은 특수 도구를 이용한 절개를 수반하는 의료적 개입을 포함하며, 일반적으로 수술실과 같은 통제된 환경에서 이루어지며, 종종 마취 및 호흡 보조를 필요로 합니다. 오피오이드는 수술 중 통증 관리를 위해 수술 중 중요한 역할을 하며, 마취 보조제 또는 주요 마취제 역할을 하기도 합니다. 예를 들어, 2023년 8월 프랑스에 본부를 둔 정부 간 기구인 경제협력개발기구(OECD)의 데이터에 따르면, 체코의 백내장 수술 건수는 2021년 131,612건에서 2022년 142,670건으로 8.4% 증가하였습니다. 또한 튀르키예의 살서제 탈장 복강경 수술 건수는 2021년 18,739건에서 2022년 25,348건으로 35.2% 급증했습니다. 따라서 외과 수술 증가는 오피오이드 시장을 견인할 태세를 갖추고 있습니다.

만성질환의 급증은 급성장하는 오피오이드 시장의 매우 중요한 촉진제가 될 것으로 예상됩니다. 만성질환은 비감염성 질환(NCDs)이라고도 불리며, 서서히 진행되고 장기간 지속되는 것이 특징인 지속적인 질병을 포괄합니다. 이러한 질병은 일반적으로 장기간 지속되며, 자연 치유 없이 수년 또는 평생 동안 지속되는 경우가 많습니다. 만성 질환의 급증은 오피오이드 시장의 핵심 요소입니다. 만성 질환과 만성 통증으로 고통받는 인구가 증가함에 따라 오피오이드에 대한 수요는 증가 추세에 있습니다. 만성질환 관리에서 오피오이드의 사용은 헬스케어 분야에서 역동적으로 진화하고 있으며, 통증 완화에 효과적인 것으로 알려져 있습니다. 예를 들어, 스위스에 본부를 둔 건강 문제 전문 기관인 세계보건기구(WHO)에 따르면, 만성질환은 전 세계적으로 큰 부담으로 작용하고 있으며, 매년 4,100만 명이 사망하고 전체 사망자의 74%를 차지한다고 합니다. 이 중 심혈관 질환은 1,790만 명, 암은 930만 명, 만성 호흡기 질환은 410만 명, 당뇨병은 200만 명의 사망 원인이 되고 있습니다. 결과적으로 만성질환의 유병률 증가가 오피오이드 시장의 성장을 가속하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Opioids refer to a class of potent medications derived from the opium poppy plant or synthesized in laboratories. They exert their effects on the nervous system to alleviate pain. Opioids are highly effective in managing moderate to severe pain, including post-surgery pain, cancer-related pain, and chronic pain disorders. They are also used to address issues such as coughing and diarrhea.

The primary types of opioid products include methadone, codeine, fentanyl, oxycodone, morphine, hydrocodone, and others. Methadone is a medication utilized in opioid addiction treatment programs to help individuals reduce or cease their use of heroin or other opioids. Opioids work by binding to various receptors, including strong agonists and mild to moderate agonists, in the nervous system. They are administered for a range of symptoms and indications, including inflammatory conditions, musculoskeletal pain, neuropathic pain, and cancer pain. Opioid medications are available in hospitals, retail pharmacies, and online pharmacies and are used in various medical applications, such as pain management, cough treatment, and diarrhea treatment.

The opioids market research report is one of a series of new reports from The Business Research Company that provides opioids market statistics, including the opioids industry's global market size, regional shares, competitors with an opioids market share, detailed opioids market segments, market trends and opportunities and any further data you may need to thrive in the opioid industry. This opioid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The opioids market size has grown steadily in recent years. It will grow from $23.54 billion in 2024 to $24.22 billion in 2025 at a compound annual growth rate (CAGR) of 2.9%. The growth in the historic period can be attributed to pain management, surgical procedures, palliative care, regulatory environment.

The opioids market size is expected to see steady growth in the next few years. It will grow to $27.62 billion in 2029 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to non-cancer pain indications, regulatory changes, telemedicine and remote prescribing, chronic pain management. Major trends in the forecast period include opioid-sparing strategies, medication-assisted treatment (mat), risk mitigation, public health initiatives.

The escalating number of surgical procedures is poised to act as a driving force behind the expansion of the opioids market in the foreseeable future. Surgical procedures encompass a spectrum of medical interventions involving incisions made with specialized tools, typically performed in controlled environments such as operating rooms, often necessitating the use of anesthesia or respiratory support. Opioids play a vital role during surgical procedures for managing pain and can serve as adjuncts to anesthesia or even as primary anesthetic agents. For instance, in August 2023, data from the Organization for Economic Co-operation and Development, an intergovernmental organization headquartered in France, revealed that the Czech Republic witnessed an 8.4% increase in the total number of cataract surgical procedures, rising from 131,612 procedures in 2021 to 142,670 in 2022. Furthermore, the total count of laparoscopic repairs for inguinal hernia surgical procedures in Turkey surged by 35.2%, reaching 25,348 in 2022 from 18,739 in 2021. Hence, the upswing in surgical procedures is poised to propel the opioids market.

The mounting prevalence of chronic diseases is expected to be a pivotal driver for the burgeoning opioids market. Chronic diseases, also recognized as non-communicable diseases (NCDs), encompass a spectrum of persistent medical conditions characterized by gradual progression and prolonged duration. These ailments typically endure over an extended period, often persisting for years or even throughout a lifetime, without spontaneous resolution. The burgeoning prevalence of chronic diseases constitutes a central element of the opioids market. With a growing population afflicted by chronic ailments and enduring chronic pain, the demand for opioids is on the rise. Opioid utilization within the context of chronic disease management is a dynamic and evolving facet of healthcare, renowned for its effectiveness in pain relief. For example, according to the World Health Organization, an agency specialized in health matters and headquartered in Switzerland, chronic diseases contribute to a substantial global burden, causing 41 million deaths each year, accounting for 74% of all fatalities. Among these chronic diseases, cardiovascular diseases cause 17.9 million deaths, cancer leads to 9.3 million deaths, chronic respiratory diseases result in 4.1 million deaths, and diabetes is responsible for 2.0 million deaths. Consequently, the escalating prevalence of chronic diseases is fostering the growth of the opioids market.

Prominent companies operating in the opioid market are dedicated to pioneering advanced pharmaceutical solutions to strengthen their market position. The development of novel medications holds the potential to treat diseases, elevate healthcare standards, and contribute to scientific knowledge. For instance, in May 2023, Braeburn Pharmaceuticals Inc., a U.S.-based provider of solutions for opioid addiction treatment, announced the U.S. Food and Drug Administration's approval of Brixadi (buprenorphine) extended-release subcutaneous injection for the management of moderate to severe opioid use disorder (OUD). This marks the first and only weekly and monthly subcutaneous injection for moderate to severe OUD, employing the innovative FluidCrystal Injection Depot Technology. The prescription recommendations allow patients receiving oral buprenorphine-containing medications to transition to equivalent dosages if followed.

In March 2023, Indivior PLC, a U.S.-based specialty pharmaceuticals company, acquired Opiant Pharmaceuticals Inc. for $145 million. This acquisition empowers Indivior to establish a comprehensive and relevant treatment platform to address the ongoing opioid and overdose crisis in the United States. It bolsters Indivior's addiction treatment and scientific portfolio by incorporating Opiant's late-stage assets, particularly OPNT003. Opiant Pharmaceuticals Inc. is a U.S.-based developer of therapies designed to combat opioid drug overdose and addiction.

Major companies operating in the opioids market are Pfizer Inc., Johnson & Johnson Inc., AbbVie Inc., Sanofi S.A, AstraZeneca PLC, Viatris Inc., Teva Pharmaceutical Industries Limited, Sandoz Inc., Sun Pharmaceutical Industries Limited, Aurobindo Pharma Limited, Purdue Pharma L.P., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals PLC, Alkermes PLC, Lannett Co Inc., Par Pharmaceutical Inc., Mayne Pharma Group Ltd., Cephalon LLC, Insys Therapeutics Inc., Janssen Pharmaceuticals Inc., Rhodes Pharmaceuticals L.P, KVK Tech Inc.

North America was the largest region in the opioids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in opioids report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the opioids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The opioids market consists of sales of oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Opioids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on opioids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for opioids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The opioids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Opioids Market Characteristics

3. Opioids Market Trends And Strategies

4. Opioids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Opioids Growth Analysis And Strategic Analysis Framework

6. Opioids Market Segmentation

7. Opioids Market Regional And Country Analysis

8. Asia-Pacific Opioids Market

9. China Opioids Market

10. India Opioids Market

11. Japan Opioids Market

12. Australia Opioids Market

13. Indonesia Opioids Market

14. South Korea Opioids Market

15. Western Europe Opioids Market

16. UK Opioids Market

17. Germany Opioids Market

18. France Opioids Market

19. Italy Opioids Market

20. Spain Opioids Market

21. Eastern Europe Opioids Market

22. Russia Opioids Market

23. North America Opioids Market

24. USA Opioids Market

25. Canada Opioids Market

26. South America Opioids Market

27. Brazil Opioids Market

28. Middle East Opioids Market

29. Africa Opioids Market

30. Opioids Market Competitive Landscape And Company Profiles

31. Opioids Market Other Major And Innovative Companies

32. Global Opioids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Opioids Market

34. Recent Developments In The Opioids Market

35. Opioids Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기